High prevalence of fluoroquinolone- and methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in Veterinary Teaching Hospital

Journal of Microbiology and Biotechnology

Volumn 20, Issue 4, 2010, Pages 798-802

  Yoo, Jong Hyun ^a   Yoon, Jang W ^b   Lee, So Young ^a   Park, Hee Myung ^a  

^a Konkuk University   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

Antibiotic resistance; Dogs; Fluoroquinolone; mecA gene; Prevalence; Staphylococcus pseudintermedius

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; LEVOFLOXACIN; METICILLIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN BINDING PROTEIN 2A; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; DOG DISEASE; EXTERNAL OTITIS; GENE IDENTIFICATION; IN VITRO STUDY; KOREA; NONHUMAN; POLYMERASE CHAIN REACTION; PYODERMA; STAPHYLOCOCCUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS; STRAIN IDENTIFICATION; TEACHING HOSPITAL; VETERINARY MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA, BACTERIAL; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; METHICILLIN; OTITIS EXTERNA; POLYMERASE CHAIN REACTION; PYODERMA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 77954970821     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0910.10044     Document Type: Article

References (29)

1. Balfour, J. A. and L. R. Wiseman. 1999. Moxifloxacin. Drugs 57: 363-373.
2. Bannoehr, J., A. Franco, M. Iurescia, A. Battisti, and J. R. Fitzgerald. 2009. Molecular diagnostic identification of Staphylococcus pseudintermedius. J. Clin. Microbiol. 47: 469-471.
3. Bisognano, C., P. Vaudaux, P. Rohner, D. P. Lew, and D. C. Hooper. 2000. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 44: 1428-1437.
4. Cohn, L. A., A. T. Gary, W. H. Fales, and R. W. Madsen. 2003. Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts. J. Vet. Diagn. Invest. 15: 338-343.
5. Devriese, L. A., M. Vancanneyt, M. Baele, M. Vaneechoutte, E. De Graef, C. Snauwaert, et al. 2005. Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int. J. Syst. Evol. Microbiol. 55: 1569-1573.
6. Ganiere, J. P., C. Medaille, and C. Mangion. 2005. Antimicrobial drug susceptibility of Staphylococcus intermedius Clinical isolates from canine pyoderma. J. Vet. Med. B 52: 25-31.
7. Gottlieb, S., D. Wigney, P. Martin, J. Norris, R. Malik, and M. Govendir. 2008. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones. Aust. Vet. J. 86: 147-152.
8. Hoekstra, K. A. and R. J. Paulton. 1996. Antibiotic sensitivity of Staphylococcus aureus and Staph. intermedius of canine and feline origin. Lett. Appl. Microbiol. 22: 192-194.
9. Ihrke, P., M. Papich, and T. Demanuelle. 1999. The use of fluoroquinolones in veterinary dermatology. Vet. Dermatol. 10: 193-204.
10. Intorre, L., M. Vanni, D. Di Bello, C. Pretti, V. Meucci, R. Tognetti, G Soldani, G. Cardini, and O. Jousson. 2007. Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi. J. Vet. Pharmacol. Ther. 30: 464-469.
11. Jones, R. D., S. A. Kania, B. W. Rohrbach, L. A. Frank, and D. A. Bemis. 2007. Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005). J. Am. Vet. Med. Assoc. 230: 221-227.
12. Lee, J. 1994. Staphylococcus intermedius isolated from dog-bite wounds. J. Infect. 29: 105.
13. Lee, K., K. H. Park, S. H. Jeong, H. S. Lim, J. H. Shin, D. Yong, G. Y. Ha, Y. Chong, and K. group. 2006. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance. Yonsei Med. J. 47: 43-54.
14. Lee, Y. J., J. K. Cho, K. S. Kim, R. B. Tak, A. R. Kim, J. W. Kim, S. K. Im, and B. H. Kim. 2005. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken. J. Microbiol. 43: 391-397.
15. Lloyd, D., A. Lamport, W. Noble, and S. Howell. 1999. Fluoroquinolone resistance in Staphylococcus intermedius. Vet. Dermatol. 10: 249-251.
16. Loeffler, A., M. Linek, A. Moodley, L. Guardabassi, J. Sung, M. Winkler, R. Weiss, and D. Lloyd. 2007. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet. Dermatol. 18: 412-421.
17. Lyskova, P., M. Vydrzalova, and J. Mazurova. 2007. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa. J. Vet. Med. A Physiol. Pathol. Clin. Med. 54: 559-563.
18. NCCLS. 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved standard. CLSI document M31-A3. NCCLS, Wayne, PA.
19. NCCLS. 2009. Performance Standards for Antimicrobial Susceptibility Testing, Nineteenth Informational Supplement. CLSI document M100-S19 NCCLS, Wayne, PA.
20. Pedersen, K., H. Jensen, K. Finster, V. F. Jensen, and O. E. Heuer. 2007. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs. J. Antimicrob. Chemother. 60: 775-781.
21. Pellerin, J. L., P. Bourdeau, H. Sebbag, and J. M. Person. 1998. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Comp. Immunol. Microbiol. Infect. Dis. 21: 115-133.
22. Ruiz, J. 2003. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51: 1109-1117.
23. Ruscher, C., A. Lubke-Becker, C. G. Wleklinski, A. Soba, L. H. Wieler, and B. Walther. 2009. Prevalence of methicillin-resistant Staphylococcus pseudintermedius isolated from clinical samples of companion animals and equidaes. Vet. Microbiol. 136: 197-201.
24. Shimizu, A., Y. Wakita, S. Nagase, M. Okabe, T. Koji, T. Hayashi, et al. 2001. Antimicrobial susceptibility of Staphylococcus intermedius isolated from healthy and diseased dogs. J. Vet. Med. Sci. 63: 357-360.
25. Tanner, M. A., C. L. Everett, and D. C. Youvan. 2000. Molecular phylogenetic evidence for noninvasive zoonotic transmission of Staphylococcus intermedius from a canine pet to a human. J. Clin. Microbiol. 38: 1628-1631.
26. Van Hoovels, L., A. Vankeerberghen, A. Boel, K. Van Vaerenbergh, and H. De Beenhouwer. 2006. First case of Staphylococcus pseudintermedius infection in a human. J. Clin. Microbiol. 44: 4609-4612.
27. Venezia, R. A., B. E. Domaracki, A. M. Evans, K. E. Preston, and E. M. Graffunder. 2001. Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J. Antimicrob. Chemother. 48: 375-381.
28. Weber, S. G., H. S. Gold, D. C. Hooper, A. W. Karchmer, and Y. Carmeli. 2003. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg. Infect. Dis. 9: 1415-1422.
29. Zubeir, I. E., T. Kanbar, J. Alber, C. Lammler, O. Akineden, R. Weiss, and M. Zschock. 2007. Phenotypic and genotypic characteristics of methicillin/oxacillin-resistant Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations. Vet. Microbiol. 121: 170-176.